Treatment Options for Melasma
The most effective treatment approach for melasma combines topical therapies, sun protection, and potentially advanced procedures like autologous platelet concentrates (APCs), with hydroquinone being the first-line topical agent for gradual bleaching of hyperpigmented skin. 1, 2
First-Line Treatments
Topical Therapies
- Hydroquinone 4% is FDA-indicated for the gradual bleaching of hyperpigmented skin conditions including melasma 1
- Tretinoin can be used alone or in combination with hydroquinone 2, 3
- Corticosteroids are often combined with hydroquinone and tretinoin in triple combination formulations 2, 3
- Azelaic acid serves as an alternative lightening agent for those who cannot tolerate hydroquinone 3
- Tranexamic acid in topical form shows efficacy, though less than oral administration 4
Sun Protection
- Strict sun protection with broad-spectrum sunscreen is essential and considered the foundation of any melasma treatment regimen 2, 5
- Patients should be counseled to avoid other damaging habits such as smoking 2
Second-Line Treatments
Oral Medications
- Oral tranexamic acid (typically 250mg twice daily) has demonstrated 25% reduction in MASI scores after 8 weeks of treatment 4
- Oral tranexamic acid should be considered for cases unresponsive to topical therapies after approximately 12 weeks 6
- Patients must be carefully screened for contraindications and thromboembolic risk factors before starting oral tranexamic acid 6
Procedural Treatments
- Chemical peels serve as a good adjunct to topical therapies 3
- Autologous platelet concentrates (APCs) including platelet-rich plasma (PRP) have shown promising results in treating melasma 2
- PRP injections have demonstrated significant improvement in melasma within 6 weeks of treatment as measured by mMASI scores 2
- Microneedling may be more effective than intradermal PRP injections for melasma treatment 2
- Laser treatments can be considered but results are variable 3, 7
Treatment Algorithm
Initial Approach:
For Resistant Cases (after 8-12 weeks of topical treatment):
Advanced Options:
Important Considerations
- Melasma should be managed as a chronic condition requiring regular follow-ups 2
- Treatment efficacy is commonly measured using the Melasma Area and Severity Index (MASI) or modified MASI (mMASI) 2
- Modified Kligman's regimen (containing hydroquinone, tretinoin, and corticosteroid) has shown superior efficacy with 30% reduction in MASI scores compared to oral tranexamic acid (25%) and topical tranexamic acid (5%) 4
- Despite its superior efficacy, modified Kligman's regimen has potential side effects with long-term usage 4
- Nanotechnology-based topical formulations are emerging as promising delivery systems that may enhance penetration while limiting systemic absorption 7
Common Pitfalls and Caveats
- Melasma is highly resistant to treatment and has a high recurrence rate 5
- Hyperpigmentation treatment alone is often ineffective unless combined with regenerative methods and strict photoprotection 5
- Long-term use of hydroquinone may lead to ochronosis and other side effects 3
- Patient education about the chronic nature of melasma and realistic expectations is crucial for treatment adherence 5
- Genetic factors and hormonal influences may limit treatment success in some patients 2, 5